Literature DB >> 3510030

Prostatic evaluation by transrectal endosonography: detection of carcinoma.

M D Rifkin, G W Friedland, L Shortliffe.   

Abstract

Transrectal endosonography is one of the most sensitive techniques to evaluate prostatic disease and is far more accurate than conventional sonography. A retrospective review of sonographic characteristics of the prostate was made in an attempt to define the ability of the technique to distinguish benign from malignant disease. Analysis included evaluation of the capsule (smoothness, regularity, and/or invasion), abnormal foci (echogenicity, margination, brightness, thickness, and symmetry), and presence of acoustic shadowing and/or enhancement from the abnormal foci. Evaluation of 443 pathologically proved cases (the majority being large lesions) showed that differentiation between benign and large and/or invasive malignant disease may be suggested by results of transrectal endosonography. However, there is still great overlap of the sonographic appearances.

Entities:  

Mesh:

Year:  1986        PMID: 3510030     DOI: 10.1148/radiology.158.1.3510030

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

Review 1.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

2.  Usefulness of aspiration cytology in prostate cancer detection.

Authors:  H Ito; K Yamaguchi; T Kotake; O Matsuzaki; K Nagao
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

3.  Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study.

Authors:  E P Allhoff; S G Liedke; O Gonnermann; C G Stief; U Jonas; B Schneider
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 4.  Screening for prostate cancer.

Authors:  M L Cher; P R Carroll
Journal:  West J Med       Date:  1995-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.